What's in Sebela Women's Health Inc.'s pipeline?

Sebela Women's Health Inc. has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Sebela Women's Health Inc.'s portfolio?

Top competitors by shared drug class: Eli Lilly and Company, Sydney Centre for Reproductive Health Research, Wyeth is now a wholly owned subsidiary of Pfizer.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/sebela-women-s-health-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Sebela Women's Health Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sebela Women's Health Inc. pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
LevoCept	LevoCept	phase 3	Selective Estrogen Receptor Modulator (SERM)	Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ)	Women's Health / Endocrinology
VeraCept	VeraCept	phase 3	11β-HSD2 inhibitor	11β-HSD2	Endocrinology

Therapeutic area mix

Endocrinology · 1
Women's Health / Endocrinology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Eli Lilly and Company · 1 shared drug class
Sydney Centre for Reproductive Health Research · 1 shared drug class
Wyeth is now a wholly owned subsidiary of Pfizer · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Sebela Women's Health Inc.:

Cite this brief

Drug Landscape (2026). Sebela Women's Health Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/sebela-women-s-health-inc. Accessed 2026-05-17.